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Abstract
Human papillomavirus (HPV) is the most important causative agent of cervical cancers worldwide. However, our
understanding of how the vaginal microbiota might be associated with HPV infection is limited. In addition, the influence of
human genetic and physiological factors on the vaginal microbiota is unclear. Studies on twins and their families provide
the ideal settings to investigate the complicated nature of human microbiota. This study investigated the vaginal
microbiota of 68 HPV-infected or uninfected female twins and their families using 454-pyrosequencing analysis targeting
the variable region (V2–V3) of the bacterial 16S rRNA gene. Analysis of the vaginal microbiota from both premenopausal
women and HPV-discordant twins indicated that HPV-positive women had significantly higher microbial diversity with a
lower proportion of Lactobacillus spp. than HPV-negative women. Fusobacteria, including Sneathia spp., were identified as a
possible microbiological marker associated with HPV infection. The vaginal microbiotas of twin pairs were significantly more
similar to each other than to those from unrelated individuals. In addition, there were marked significant differences from
those of their mother, possibly due to differences in menopausal status. Postmenopausal women had a lower proportion of
Lactobacillus spp. and a significantly higher microbiota diversity. This study indicated that HPV infection was associated with
the composition of the vaginal microbiota, which is influenced by multiple host factors such as genetics and menopause.
The potential biological markers identified in this study could provide insight into HPV pathogenesis and may represent
biological targets for diagnostics.
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Introduction
Vaginal microbiota play a crucial protective role in women’s
health, and the host biochemical and immunological response to
the microbiota can serve as an indicator of the health indicators of
the vaginal environment [1]. A healthy microbiota prevents or
hinders many urogenital diseases, such as yeast infections, sexually
transmitted infections, urinary tract infections, and human
immunodeficiency virus (HIV) infection [2,3,4,5,6]. An abnormal
microbiota, such as that found in bacterial vaginosis (BV), is
associated with an increased risk of upper genital tract health
issues, miscarriage [7], recurrent abortion [8], preterm delivery
[8], HPV infection [9], and sexually transmitted infections,
including HIV [10]. A healthy vaginal microbiota is composed
primarily of lactic acid-producing bacteria such as Lactobacillus
spp., which are commonly found on the vaginal epithelium, and
contribute to women’s health by maintaining a low pH in the
vagina through lactic acid production. In addition, the microbiota
inhibit competing bacterial taxa by producing bacteriocins, which
kill closely related bacterial species, and biosurfactants, which
prevent the attachment of other species to the epithelium [11].
With the advancement of sequencing technologies, tools for
investigating the human microbiome in various body sites have
become available [11]. Most previous research on the vaginal
microbiota focused on the composition of the vaginal microbiota
of healthy women or those with BV [1,12,13], although more
recently, an association between the vaginal microbiota and HIV
infected women was reported [14,15,16].
Cervical cancer is the third most common cancer in women
worldwide [17], and human papillomaviruses (HPVs) are consid-
ered to be the most important sexually transmitted causal agent of
cervical intraepithelial neoplasia (CIN) and cervical adenocarci-
noma [18,19], although the association with cervical cancer is
confined to specific high-risk types of HPV. High-risk types of
HPV are strongly associated with cervical cancer and are detected
in 99% of cervical cancers, whereas low-risk types are associated
with benign or less malignant genital warts [20]. HPVs are
common in the anogenital mucosa of sexually active adults and
adolescents, and most HPVs have been found in this body region
[20,21,22]. The age-adjusted prevalence of HPV in women is
estimated to be 10.4%, ranging from 8.1% in Europe to 22.1% in
Africa [23]. To-date, age, sexual activity, menopausal status, and
hormone therapy have been found to be associated with the
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development and persistence of HPV infection [23]. However,
other factors associated with anogenital HPV infection are poorly
understood, despite the vaginal microbiota, mucosal immunity,
the level of estrogen hormones, and host genetic factors having
been assumed to play important roles in HPV susceptibility.
Studies on twins and their mothers can provide valuable
information for discriminating the effects of genetic and various
environmental factors on vaginal microbiota [24,25]. In this study,
we investigated the association between the vaginal microbiota
and HPV infection using a twin cohort with consideration of
menopausal status. In addition, potential microbiological markers
associated with HPV infection were investigated.
Materials and Methods
Study Population
This study was performed using cervicovaginal samples
collected from 912 women who participated in the Healthy Twin
Study, a part of the Korean Genome Epidemiology Study [26].
The zygosity of twins was tested using the AmpFlSTR Identifier
Kit (Perkin Elmer, Waltham, MA, USA) with 16 short tandem
repeat (STR) markers (15 autosomal STR markers and 1 sex-
determining marker) in 67% of the twins. For the remaining 33%,
a zygosity-determining questionnaire with a validated accuracy of
.90% was applied [27]. All subjects were between 31 and 73
years of age. Written informed consent was obtained from each
participant. The study protocol was approved by the Korea
Centers for Disease Control and the institutional review board
(IRB) of the three participating institutions: Samsung Medical
Center, Inje University Busan Paik Hospital, and Seoul National
University (IRB No. 144-2011-07-11).
Sample Collection and HPV Screening
In the selection of these samples, we examined 912 women who
had undergone a Pap smear test between 2005 and 2009 in South
Korea as part of the health examination for the Healthy Twin
Study. The average age of twins and siblings was 43 and that of
their mothers was 65. Each cervicovaginal sample was collected
with a separate endocervical brush. The liquid-based preparation
method for collecting cervicovaginal samples was performed
according to the manufacturer’s instructions (ThinPrepH and
SurepathTM) and stored until further analysis [28]. Whole
genomic DNA was extracted from each of the 980 sample swabs
collected from 912 twins, siblings, and their mothers; to determine
the presence of HPV infection, 912 subjects were tested for HPV
using two primer sets, MY09/MY11 and GP5+/GP6+, as
described in a previous study [18]. PCR amplicons of 450 and
150 bp were sequenced for confirmation and subsequent typing of
HPV (high vs. low risk). HPV genotypes 16, 18, 33, 35, 39, 45, 51,
52, 56, 58, 59, and 66 were identified as high risk and the others
were identified as low risk. Among the 912 subjects, 72 (7.9%)
were positive for HPV infection; of these 72 subjects, those who
had received antibiotics in the 6-month period prior to specimen
sampling were excluded.
In addition, patients with Trichomonas vaginalis infection and/or
atypical cells of undetermined significance (ASCUS), as deter-
mined by clinical examination, were also excluded to eliminate
possible confounding effects associated with these agents. As a
result, we chose 23 HPV-positive and 45 HPV-negative subjects.
The 23 HPV-positive subjects included 10 HPV-discordant MZ
twins (HPV positive, without CIN [N=9]; HPV positive with CIN
[N=1]), four HPV-positive concordant MZ twin pairs (both MZ
twin pairs were HPV positive), five HPV-positive unpaired MZ or
DZ twins (HPV-positive twins where the matching twin was
excluded based on the criteria described above, N= 5), and four
siblings (N= 4). The 45 HPV-negative subjects included HPV-
discordant MZ twins (N= 10), HPV-negative concordant MZ
twins (N= 2), DZ paired twin pair (N= 2), HPV-negative unpaired
MZ twin (N= 6), siblings (N=15), and mothers (N= 10). The
epidemiological and clinical information of the study population
are summarized in Table S1.
Among the study subjects (N=68), 50 and 18 were pre- and
postmenopausal women as identified by self reporting, respective-
ly. Postmenopausal women included some of the twins (N= 4),
their siblings (N= 4), and all of the twins’ mothers (N= 10). Among
the 18 postmenopausal women, three had a history of hormone
replacement therapy (HRT). To determine the effect of HPV
infection on vaginal microbiota and women’s health, 50 subjects
from three subgroups–HPV negative and CIN negative (N= 26),
HPV positive and CIN negative (N=19), and CIN positive (N= 5;
four HPV-positive and one HPV-negative subjects)–were selected.
Postmenopausal women and those with noticeable infection on
physical examination were excluded from this portion of the study.
We included only 26 women as HPV-negative healthy controls
from the 50 premenopausal women after exclusion of subjects with
HPV, other noticeable infections, or CIN. Among the five women
with CIN, four were identified as HPV positive. For the analysis of
HPV-discordant twins, only nine MZ twin pairs (N= 18) without
CIN, who were 31249 years old, were selected. One discordant
twin pair with CIN was excluded from this analysis due to possible
interference with clinical symptoms. Table 1 summarizes the study
population.
DNA Extraction, PCR Amplification of 16S rRNA, and
Purification
Total genomic DNA was extracted from each swab (N= 68)
using an extraction kit. Genomic DNA was extracted from the
cytobrush using the chemagic viral DNA/RNA kit (Chemagen,
Baesweiler, Germany) according to the manufacturer’s instruc-
tions. The extraction method for total nucleic acids was compared
with the conventional bead beating method using 16S rRNA
amplification and DGGE analysis. No significant difference was
observed. The extracted nucleic acids were stored at 270uC until
use. The V2 and V3 regions of the 16S rRNA genes were
integrally amplified by polymerase chain reaction (PCR) using the
barcoded universal primers presented in Table S2, and pyrose-
quenced using the 454 Life Sciences FLX Titanium machine
(Roche, Indianapolis, IN, USA). For each sample, we amplified
the 16S rRNA genes using the primer set 8 forward and 534
reverse [29,30]. The forward primer contained the 454 Life
Sciences (Roche) Titanium-compatible adaptor sequences (59-
CCTATCCCCTGTGTGCCTTGGCAGTC-39), a four-base
linker sequence (‘‘TCAG’’), and the broadly conserved bacterial
primer 8F (59-AGAGTTTGATCCTGGCTCAG-39). The reverse
primer contained the 454 Life Sciences (Roche) Titanium-
compatible adaptor sequences (59-CCATCT-
CATCCCTGCGTGTCTCCGAC-39), a four-base linker se-
quence (‘‘TCAG’’), and a 9- or 10-base multiplex identifier
(MID) used to tag each PCR product, the bacterial primer 534R
(59-ATTACCGCGGCTGCTGG-39) (Table S2). PCR reactions
consisted of 0.5 mM of each forward and reverse primer, about
50 ng/mL template DNA, 16 PCR reaction buffer, 400 mM
dNTP mix, and 2.5 U G-Taq polymerase (Cosmo, Seoul, Korea).
Samples were initially denatured at 94uC for 5 min and then
amplified for 35 cycles at 94uC for 45 s, 55uC for 30 s, and 72uC
for 90 s. A final extension of 10 min at 72uC was added at the end
of the program to ensure complete amplification of the target
region. Amplified PCR products were purified using the QIAquick
Vaginal Microbiota and HPV Infection
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PCR Purification Kit (Qiagen, Valencia, CA, USA). The resulting
samples were sent to Macrogen (Seoul, Korea) for pyrosequencing
on a 454 Life Sciences Genome Sequencer FLX Titanium
machine (Roche). Multiplex pyrosequencing of 68 samples (after
filtering) produced 390,444 high-quality 16S rRNA sequences
with an average length of 474 bp and 5,741 reads per sample.
These sequence data have been submitted to the European
Nucleotide Archive under the study number ERP001901.
Sequence Analysis using QIIME
Data were analyzed using Quantitative Insights Into Microbial
Ecology (QIIME) 1.2.0 (http://qiime.sourceforge.net) [31]. Before
analyzing the sequences, denoising of the sequence data set was
performed [32]. Low-quality sequences were removed (,200 bp),
and the 9- or 10-bp barcode was examined to assign sequences to
samples. Pyrosequencing data were processed using the QIIME
pipeline. Phylotypes were identified using UCLUST and defined
at the 97% sequence similarity level. A representative sequence
from each phylotype was aligned using PyNAST [33], and the
taxonomic identity of each phylotype was determined using the
RDP classifier [34]. Lactobacillus species level was further identified
using the Rtax method with a pre-clustered Greengene database
(gg_97_otus_4feb2011.fasta) [35]. The differences between each
sample pair were determined from a neighbor-joining tree using
the weighted UniFrac [36]. Heatmaps of the microbial taxa
according to subject were generated by mapping using Multi-
Experiment Viewer software (version 4.8.01; http://www.tm4.org)
[37]. The hierarchical clustering of the bacterial microbiota
among subjects was analyzed using Spearman’s correlation.
Association between Vaginal Microbiota and Phenotype
by LEfSe Analysis
To identify a microbiological marker of a vaginal microbiota
associated with HPV infection, sequence analyses were performed
using a pyrosequencing pipeline with Mothur [38], abundantOTU
[39], and PERL scripts. To qualify for analysis, a sequence had to
be at least .200 bp or ,600 bp in length, have a read quality
score .25, and have a barcode match. Each processed sequence
was assigned, and the barcode and primer sequences were
trimmed. All processed sequences were aligned by the NAST-
based sequence aligner to custom references based on the SILVA
alignment [38]. The Mothur package of the ChimeraSlayer
algorithm [40] was used to identify the chimeric sequences. After
sequence identification, sequences were clustered into OTUs using
abundantOTU [39]. Representative sequences per OTU were
classified using the MSU RDP classifier v2.2 maintained at the
Ribosomal Database Project (RDP 10 database, v6). Finally, the
abundant OTUs were used in the LEfSe (linear discriminant
analysis [LDA] coupled with effect size measurements) to
characterize the potential microbial OTU markers with specific
disease phenotype [41]. SPSS (ver. 19.0; Armonk, NY, USA) was
used to perform either the t-test or the Wilcoxon signed-rank test.
Results and Discussion
1) Composition of the Vaginal Microbiota in the Twin
Cohort
In this study, we investigated the compositional differences
between the vaginal microbiota of healthy and HPV-positive
individuals using 68 Korean twins and their family members.
Vaginal microbiota composition varied significantly among
individual subjects (Fig. 1 and Figure S1). The vast majority of
the vaginal microbiota belonged to one of six major phyla:
Firmicutes, Bacteroidetes, Fusobacteria, Actinobacteria, Tener-
icutes, and Proteobacteria (Table S3A). Of these, Firmicutes, to
which Lactobacillus spp. belong, was the most abundant (.77%) in
normal premenopausal women [42]. However, in postmenopausal
women, the proportion of Firmicutes, including Lactobacillus spp.,
was much lower (,57%), and Proteobacteria were significantly
more abundant, including species in the families Enterobacteria-
ceae and Caulobacteraceae, in addition to Streptococcus spp. and
Anaerococcus spp. (Table S3). These results are consistent with a
previous culture-based study reporting a higher proportion of
vaginal Proteobacteria (i.e., Escherichia coli) in postmenopausal
women than premenopausal women [43].
As described above, Lactobacillus spp. was the most abundant
microorganism. Of the Lactobacillus species identified in vaginal
microbiotas, L. iners and L. crispatus were most abundant (29.5% for
L. iners, and 21.4% for L. crispatus) in this study (Fig. 1A, and Figure
S1). In addition, L. jensenii were identified in only 1.4% of subjects,
while no L. gasseri were found. These results are in accordance with
a previous report of the vaginal microbiomes in reproductive-age
Asian women [13]. Specifically, the communities clustered into
five groups (clusters I–V). Our subjects who were also Asian,
belonged mostly to cluster III (L. iners) and cluster I (L. crispatus).
The prevalence of HPV infection did not differ significantly based
on the type of vaginal microbiota (36.6% for cluster III (L. iners),
and 21.5% for cluster I (L. crispatus) or menopausal status (16.6%
for L. iners, and 16.2 for L. crispatus). The prevalence of HPV
infection did not differ between clusters (cluster III and cluster I) of
Lactobacillus spp. (p = 0.17). Regardless of the Lactobacillus spp.
cluster, the observed decrease in the prevalence of Lactobacillus spp.
in subjects that had undergone menopause was consistent with the
results of a previous study [44].
We performed LEfSe analysis using both premenopausal
healthy women with and without HPV infection (N= 45) to
Table 1. Summary of the study population (N= 68).
Premenopausal women (N=50) Postmenopausal women (N=18) Sum





































Sum 27 23 18 0 68
{The number with cervical intraepithelial neoplasia (CIN).
doi:10.1371/journal.pone.0063514.t001
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identify a potential microbiological predictor of HPV infection
(Fig. 1B) and high-risk HPV (HPV genotype 16 [N=2], 18
[N=2], 39 [N= 3], 45 [N= 1], 52 [N= 1], 56 [N= 2], and 59
[N=2])-infected groups (N= 13) without CIN (Fig. 1C). HPV
infection was strongly associated with the abundance of various
vaginal microbiota species, particularly Fusobacteria. Sneathia spp.
were identified as microbiological markers of HPV infection
(Fig. 1C and Table S3B). Additionally, when we further analyzed
the vaginal microbiota based on HPV virulence type, Sneathia was
identified as a microbiological marker of high-risk HPV infection
(Fig. 1C and Table S3B). Sneathia was the most abundant genus,
being more than three times more frequent among women in the
high-risk HPV-infected group.
Overall, the microbial species richness, which is directly
associated with the microbial diversity of postmenopausal women,
was significantly higher than that of premenopausal women, as
indicated by the rarefaction curves in Figure 2A. These results are
consistent with a previous report that bacterial diversity is higher
in menopausal women [44]. To identify the specific taxa
differentially present or abundant between these microbiomes,
we employed the LEfSe method [45]. As expected, a higher
Lactobacillus spp. abundance was strongly associated with premen-
opausal women (Fig. 2B). Diverse microorganisms, including
species of the genera Porphyromonas, Streptococcus, Sphingomonas,
Camplylobacter, and Peptoniphilus, were significantly associated with
postmenopausal women (Fig. 2B and Table S3B). These results are
consistent with a previous report of Streptococcus abundance in
postmenopausal women [46]. Vaginal microbiotas are influenced
by estrogen levels, which also control the thickness of the vaginal
epithelial tissue. Therefore, epithelial thinning in postmenopausal
women could be responsible for the change in the distribution of
the vaginal microbiota [46]. Despite the small sample size, our
results clearly indicate that changes in the vaginal microbiota after
menopause are attributable mostly to hormonal changes. Our
Figure 1. Comparison of the vaginal microbiotas of the study population. (A) Heatmap of abundances of members of the vaginal
microbiota; red indicates a high proportion and blue shows a low proportion. (B) Comparison of HPV-negative women (N= 26) and HPV-positive
those (N= 19) without CIN. (C) Comparison of HPV-negative (N= 26) and women infected with high-risk HPV types (N= 13) without CIN.
doi:10.1371/journal.pone.0063514.g001
Vaginal Microbiota and HPV Infection
PLOS ONE | www.plosone.org 4 May 2013 | Volume 8 | Issue 5 | e63514
preliminary results suggest that the vaginal microbiotas of
postmenopausal women receiving HRT decreased dramatically
and were similar to those of premenopausal women (Figure S2).
Despite the small sample size in our study, these results are
consistent with previous reports that postmenopausal women
receiving HRT had a lower vaginal pH and a lower microbial
richness than women not receiving HRT [47].
Because menopause status was strongly-associated with the
vaginal microbiota, samples from postmenopausal women were
excluded from the investigation of the association between the
vaginal microbiota and HPV infection. After excluding the 18
postmenopausal women, we compared the vaginal microbiota of
23 HPV-positive and 27 HPV-negative premenopausal women.
Among the 23 HPV-positive premenopausal women, four had
CIN, which is a potential precursor of cervical cancer. In contrast,
only one had CIN among the 27 HPV-negative premenopausal
women. The average abundance of Lactobacillus spp. was much
lower in groups infected with HPV or with CIN than in the
premenopausal control group. In the CIN groups, the proportions
of Lachnospiraceae and Veillonella spp. became higher (Table S3).
Instead, Fusobacteria were more prevalent in the HPV-infected
group than in the uninfected or postmenopausal group (P,0.05, t-
test) (Fig. 1B and Table S3). Other microorganisms including
Prevotella spp. (phylum Bacteroidetes), Sneathia spp. (phylum
Fusobacteria), and Clostridiales (phylum Firmicutes), significantly
increased among the group with HPV infection. These results
indicate that HPV infection was significantly associated with the
composition of the vaginal microbiota.
2) Comparison of Microbiota in HPV-infected Discordant
MZ Twins
To adjust for potential genetic confounding factors, we
characterized the association between HPV infection and the
vaginal microbiota using nine HPV infection-discordant MZ twin
pairs without CIN (N=18) (Fig. 3). Despite the small sample size,
the data for the nine discordant twin pairs showed clear differences
in the vaginal microbiota between HPV-positive and negative
subjects. The occurrence of HPV infection was strongly associated
with a decrease in Lactobacillus spp. and other facultative or
anaerobic species. The percentage of Lactobacillus spp. was
significantly lower in the HPV-infected group (mean 47%) than
in the uninfected group (mean 77%). In particular, a decrease in
the abundance of L. iners in the vaginal microbiota was associated
with HPV infection among discordant MZ twins (P=0.03) (Fig. 3A
and Table S3). However, the abundance of L. crispatus was not
significantly associated with HPV infection (P=0.76). Lactobacillus
spp. are prevalent in the vagina, where they play a role in
maintaining a low pH through their metabolic activities. Thus,
Lactobacillus spp. might confer resistance to HPV infection in
addition to protecting against colonization of overt pathogens or
against dominance by potentially pathogenic species [42,48]. For
example, the E5 protein of HPV type 16 is quite susceptible to low
pH [49].
In the present study, higher proportions of Prevotella, Sneathia,
Dialister, and Bacillus species were detected in the HPV-infected
than in HPV-negative discordant MZ twin pairs (Table S3).
Prevotella and Sneathia were previously found in BV-positive women
[10]. Dialister spp. are more frequent in women of reproductive age
with a high vaginal pH [13]. The roles of these microorganisms
are not clear and should be investigated further. The vaginal
microbiota of the HPV-positive group was markedly more diverse
than that of the HPV-negative group (Fig. 3B). Increased
microbial richness (a component of species diversity) with HPV
infection was also confirmed by the average weighted UniFrac
distance between the HPV-positive twins and the negative-
discordant control (P,1028; Fig. 3C). These results suggest that
the vaginal microbiota differed significantly according to HPV
infection status, even after adjusting for genetic factors within the
MZ twins.
We performed LEfSe analysis using HPV-discordant twin pairs
(N= 18) (Fig. 3D). Sneathia and Megasphaera were significantly
associated with HPV infection. Sneathia spp. were identified in a
previous study of BV-positive women, although their HPV
infection status was unknown [1]. Species in this genus, which
are lactic acid producers like those in Lactobacillus, may represent
useful microbiological predictors of HPV infection among healthy
premenopausal women. However, in this study, the LEfSe analysis
indicated only differences in operational taxonomic units (OTUs)
and did not detect the presence or absence of Sneathia spp.
(Fig. 3D). Therefore, the specificity of Sneathia spp. as a potential
predictor of HPV infection should be evaluated further. Fusobac-
Figure 2. The effect of menopause on the vaginal microbiota. (A) Rarefaction curves for postmenopausal women (N=18) and premenopausal
women without either HPV infection or CIN (N= 26). (B) Microbiological markers of postmenopausal (N= 18) and premenopausal women without
either HPV infection or CIN (N= 26) by LEfSe.
doi:10.1371/journal.pone.0063514.g002
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teria, including Fusobacterium and Sneathia spp., typically inhabit
mammalian mucous membranes and can invade epithelial cells;
these pathogens thus cause a wide range of human infections
[41,50]. Adherence to epithelial cells is crucial for colonization,
and invasion allows the bacteria to evade the host immune
surveillance and spread into the deeper tissues [51]. These events
could elicit host pro-inflammatory responses [52] and expression
of virulence characteristics, which could further promote the
adhesiveness of Fusobacteria to host epithelial cells [53,54]. A
previous study reported that Fusobacterium spp. may be associated
with inflammatory bowel disease (IBD) [55]. Recently, Kostic et al.
reported the association of Fusobacterium with colorectal carcinoma
[41]. The results of our study are consistent with these studies, and
suggest strongly that Fusobacteria is a key dysbiosis-associated
microorganism that induces an imbalance in mucosal immunity
and subsequent adverse health effects. In this study, we used two
different bioinformatics tools (QIIME and LEfSe) to analyze the
vaginal microbiota; QIIME was used to compare the entire
microbial structure within the study subpopulation, while LEfSe
was applied to identify specific microbiological associations for
disease phenotypes. The results of both analyses clearly suggest a
strong association between HPV infection and the composition of
the vaginal microbiota.
It should be noted that our study demonstrates only an
association between the composition of the vaginal microbiota
and HPV infection. The possibility exists that a lower proportion
of Lactobacillus spp. could render the vaginal environment more
susceptible to HPV infection. Previous studies have indicated that
BV is significantly associated with sexually transmitted viral
diseases, including HPV [56,57]. However, HPV infection may
alter mucosal metabolism [46], host immunity [58], or both,
resulting in changes in the community structure of vaginal
microbiota. For example, HPVs infect stratified basal vaginal
epithelial cells, and viral particles infect the host by entering the
basal epithelial cells through a break in the skin [23]. When the
vaginal epithelium becomes thin, the levels of glycogen would be
greatly reduced. Because glycogen is typically metabolized to lactic
acid by Lactobacillus spp. in the vaginal environment, the reduction
in glycogen level is at least partially responsible for the changes in
vaginal pH, which lead to changes in the composition of the
Figure 3. A comparison of the vaginal microbiota among nine HPV infection-discordant twin pairs (N=18). (A) Heatmap of the vaginal
microbiota at the species levels of HPV infection-discordant MZ twin pairs (N= 9 each for HPV [+] and [2]). (B) Rarefaction curve for the vaginal
microbiota (mean 695% confidence interval) of nine HPV infection-discordant MZ twin pairs (N = 18). (C) Average weighted UniFrac distance
between the discordant MZ twin pairs (nine pairs [N= 18]) (***P,1028). (D) HPV-negative and HPV-positive women in nine MZ HPV-discordant twin
pairs (N= 18).
doi:10.1371/journal.pone.0063514.g003
Vaginal Microbiota and HPV Infection
PLOS ONE | www.plosone.org 6 May 2013 | Volume 8 | Issue 5 | e63514
microbiota [46]. Several previous studies have found that HIV
infection is associated with a higher vaginal microbiota diversity
[10,14]. HPV is known to infect vaginal mucosal surfaces [59,60];
mucosal immunity and inflammation typically occur during virus
infection [58], mediated by several mechanisms including the
induction of interferon and activation of macrophages and NK
cells. Pro-inflammatory cytokines, reactive oxygen species, viral
DNA integration, and chronic inflammation during HPV infection
could also result in changes in the vaginal mucosal environment,
leading to changes in the vaginal microbiota [60,61,62]. Future
studies are necessary to elucidate the causality and mechanisms of
the associations between HPV infection and changes in vaginal
microbiota.
3) Comparison of Vaginal Microbiota of MZ Twins and
their Families
Vaginal microbiota from twins, siblings, and their mothers were
compared using both weighted and unweighted UniFrac distances
(Fig. 4A and 4B). Based on both average weighted and unweighted
UniFrac distances (Fig. 4A and 4B), the vaginal microbiotas of MZ
twins were significantly more similar to each other than to the
microbiotas of unrelated individuals (P,0.05). Both average
weighted and unweighted UniFrac distances of vaginal microbi-
otas were most similar between MZ and MZ, followed by MZ-
sister, MZ-mother, and then among unrelated subjects. These
results suggest associations between genetics and the vaginal
microbiota. The similarity of the vaginal microbiotas of twins was
due to both shared OTUs (unweighted) and shared OTU
population distributions (weighted). In addition, the vaginal
microbiotas of MZ twins were much more similar than to those
of their sisters and mothers (P,0.05). The distributions of shared
OTUs of the vaginal microbiotas of twins were significantly
different from those of their sisters (P,1024). However, shared
OTUs did not differ significantly according to unweighted
UniFrac results (P.0.05). The microbiotas of MZ twins were
significantly different from those of their mothers when analyzed
by both weighted (P,0.05) and unweighted UniFrac (P,1024).
All mothers were 55273 years old and menopausal (Table S1).
Many factors differed between the twins and their parents [24]. As
described above, the menopausal status resulted in significant
differences in vaginal microbiota within the same family. These
results suggest strongly that unique genetic, physiological, and
environmental factors within the family contribute significantly to
the unique presence and distribution of the vaginal microbiota.
Conclusion
This study provides strong evidence that an increased vaginal
microbiota diversity is strongly associated with HPV infection. In
particular, Fusobacteria, including Sneathia spp., were strongly
associated with HPV infection. In addition, both the composition
and diversity of the vaginal microbiota were influenced by host
genetics, physiology, and other factors, such as menopause and
estrogen level. Potential microbiological predictors identified from
this study may provide insight into the pathogenesis of HPV and
may represent potential microbiological targets for novel diagnos-
tic methodologies that will improve women’s health status.
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